Rizzo: “I produce printers intended to create organs for bodies” – The interview with Corriere della Sera
Roberto Rizzo, President of SolidWorld GROUP, did an interview with Corriere della Sera to talk about the new 3D printer Electrospider mainly intended for regenerative medicine, as it is capable of perfectly reproducing 3D cellular constructs. This printer promises to solve two surgical problems, namely transplantation and rejection.
“Four years ago I began to see the human body as a machine, the most complex one that exists. Forget about brain, thought, consciousness. I am talking about organs that perform the most disparate functions and are compacted in a very limited and interconnected environment. We created a three-dimensional scanning software that transforms tomography and magnetic resonance imaging into digital models of these organs. Think about the advantages in the case of liver metastases: the surgeon has a perfect model in his hand, he knows where to cut. And in fact the experimentation has already been useful in cardiac and renal operations, in spina bifid, in the separations of conjoined twins" explains Roberto Rizzo, President of SolidWorld GROUP.
Article published by Corriere della Sera on 21/03/2023
Related posts
Auto-magically Delivery: Bio3DPrinting garantisce un codice sempre aggiornato per la biofabbricazione con Electrospider
Tra le possibilità sviluppate da Bio3DPrinting la distribuzione in cloud dei progetti di biostampa realizzati con la biostampante 3D Electrospider offre molteplici vantaggi significativi.
Bio3DPrinting will be present at the Termis conference in Seattle as an official sponsor
Bio3DPrinting will participate in the TERMIS-WC 2024 conference, which will be held in Seattle from June 25th to 28th as an official sponsor.
Multi-scale and multi-material constructs, the secret of Electrospider's 3D biofabrication
What was the leap in quality for Bio3DPrinting's Electrospider 3D bioprinter? The ability to create scaffolds to develop more sophisticated and accurate human tissue models using a single bioprinter.